Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.

Wang, Rongmin; Xiao, Yinping; Ma, Lingwei; Wu, Zhiyong; Xia, Hexia

Wang, Rongmin; Xiao, Yinping; Ma, Lingwei; Wu, Zhiyong; Xia, Hexia.

Affiliation

Wang R; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China, min11131990@126.com.
Xiao Y; Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Ma L; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Wu Z; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Xia H; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

Gynecol Obstet Invest ; 87(6): 398-405, 2022.

Article in En | MEDLINE | ID: mdl-36273460

Subject(s)

Carcinoma, Neuroendocrine; Uterine Cervical Neoplasms; Pregnancy; Female; Humans; Young Adult; Adult; Middle Aged; Aged; Cervix Uteri/pathology; Retrospective Studies; Neoplasm Staging; Platinum/therapeutic use; Hysterectomy/methods; Prognosis; Carcinoma, Neuroendocrine/drug therapy; Carcinoma, Neuroendocrine/surgery; Uterine Cervical Neoplasms/drug therapy; Uterine Cervical Neoplasms/surgery; Chemotherapy, Adjuvant

Key words

Adjuvant treatment; Neuroendocrine cervical carcinomas; Overall survival prognosis; Progression-free survival

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Carcinoma, Neuroendocrine Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged / Pregnancy Language: En Journal: Gynecol Obstet Invest Year: 2022 Document type: Article Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google